Atlas Trials

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Clinical trial NCT03245541 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03245541
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2020-08-14
Primary completion
2026-09-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.